Coenzyme A activates TLR4 and enhances alternative macrophage activation in line with MyD88 agonism.

Authors

Anthony E Jones, Amy Rios, Neira Ibrahimovic, Andréa B Ball, Carolina Chavez, Nicholas A Bayley, Natalie A Falta, Marisa Mekkittikul, Clarissa Carrillo, Wei Yuan Hsieh, Alessandro Sammarco, Amber B Reyes, Angel A Cortez, Thomas G Graeber, Richard L Watson, Alexander Hoffmann, Steven J Bensinger, Ajit S Divakaruni

Published in

EMBO reports. Sep 18, 2026. Epub Sep 18, 2026.

Abstract

Metabolites and metabolic cofactors can shape the innate immune response, though the pathways by which these molecules adjust inflammation remain incompletely understood. Here we show that the metabolic cofactor coenzyme A (CoA) enhances IL-4 driven alternative macrophage activation [M(IL-4)] in vitro and in vivo. Unexpectedly, we find that perturbations in intracellular CoA metabolism do not influence M(IL-4) differentiation. Rather, we discover that exogenous CoA is a weak TLR4 agonist which primes macrophages for increased receptivity to IL-4 signals and resolution of inflammation via MyD88. Mechanistic studies reveal MyD88-linked signals enhance IL-4 responsiveness, in part, by reshaping chromatin accessibility to enhance transcription of IL-4-linked genes. The results identify CoA as a host metabolic co-factor that influences macrophage function through an extrinsic TLR4-dependent mechanism and suggest that damage-associated molecular patterns (DAMPs) can prime macrophages for alternative activation and resolution of inflammation.

PMID:
42760443
Bibliographic data and abstract were imported from PubMed on 19 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.